Standard BioTools Inc.
LAB
$1.29
-$0.04-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 133.67M | 134.40M | 135.83M | 117.30M | 97.70M |
| Total Other Revenue | -- | -- | 921.00K | 921.00K | 921.00K |
| Total Revenue | 133.67M | 134.40M | 135.83M | 117.30M | 97.70M |
| Cost of Revenue | 66.83M | 67.81M | 69.27M | 59.29M | 51.79M |
| Gross Profit | 66.84M | 66.59M | 66.57M | 58.02M | 45.91M |
| SG&A Expenses | 129.92M | 126.68M | 123.27M | 107.03M | 94.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 235.62M | 234.38M | 234.59M | 201.23M | 174.84M |
| Operating Income | -101.95M | -99.98M | -98.76M | -83.93M | -77.14M |
| Income Before Tax | -102.39M | -109.51M | -102.32M | -88.45M | -82.58M |
| Income Tax Expenses | -338.00K | 310.00K | 542.00K | 108.00K | 40.00K |
| Earnings from Continuing Operations | -102.05 | -109.82 | -102.86 | -88.56 | -82.62 |
| Earnings from Discontinued Operations | -18.45M | -22.94M | -36.03M | -36.03M | -36.03M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -120.50M | -132.76M | -138.89M | -124.59M | -118.65M |
| EBIT | -101.95M | -99.98M | -98.76M | -83.93M | -77.14M |
| EBITDA | -83.46M | -81.09M | -78.84M | -64.06M | -54.05M |
| EPS Basic | -0.32 | -0.36 | -0.55 | -0.71 | -0.90 |
| Normalized Basic EPS | -0.15 | -0.15 | -0.15 | -0.21 | -0.31 |
| EPS Diluted | -0.32 | -0.36 | -0.55 | -0.71 | -0.91 |
| Normalized Diluted EPS | -0.15 | -0.15 | -0.15 | -0.21 | -0.31 |
| Average Basic Shares Outstanding | 1.50B | 1.50B | 1.41B | 1.12B | 825.34M |
| Average Diluted Shares Outstanding | 1.50B | 1.50B | 1.41B | 1.12B | 825.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |